On February 6 and 7, Gerresheimer will be showcasing its products at the Pharmapack in Paris with its new subsidiary Sensile Medical AG for the first time. In July of this year, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities. The company works closely with pharmaceutical and biotech companies to develop devices to deliver liquid drugs. At Pharmapack in Paris, Porte de Versailles, Sensile Medical will be at Stand A94 and Gerresheimer at Stand B62.
“Sensile Medical specializes in the development of key technologies for the patient-oriented delivery of liquid drugs,” says Sandra de Haan, Chief Business Officer at Sensile. Sensile Medical’s leading position in micro pump technology combined with drug delivery devices featuring electronic and connected capabilities for medical applications is progressing to market readiness in specific customer projects with pharma companies. The company is involved with pharma companies in the early stages of drug and therapy development. Sensile Medical is to become the Development Division, covering the field of development devices for the entire Gerresheimer Group. It is already working very successfully on projects with customers to develop devices for diabetics and patients with heart disease and in other treatment areas such as Parkinson’s disease.
The micro rotary piston pump – small and precise in dosage
Sensile Medical AG has developed a new kind of patented micro pump, which is the key component of all product platforms. SenseCore is small and very precise in dosage. Consisting of only two plastic parts, it can be produced at a low cost. Thanks to its high degree of flexibility, it is compatible with a variety of drugs.
Wearable micro pump certified to EU standards for Parkinson’s treatment
A wearable micro pump of this type designed specifically for the treatment of Parkinson’s received the EU certificate only recently. A European pharmaceutical company has obtained the CE declaration and will now launch the product on the market. This is makes it the first micropump by Gerresheimer’s subsidiary Sensile Medical to be used commercially. The micro pump is used in advanced Parkinson’s treatment.